Ecstasy can reduce fears and stress in PTSD patients. Here’s how.

Https%3a%2f%2fblueprint-api-production.s3.amazonaws.com%2fuploads%2fcard%2fimage%2f301764%2fc203b264550d4b6396ae25038bce4b48

Feed-twFeed-fb

When ecstasy hits, it unleashes a rush of euphoria and abundant compassion in users. That’s precisely why the drug could be an effective treatment for people suffering from post-traumatic stress disorder (PTSD), early studies show.

A large-scale clinical trial is set to move forward next year to test the therapeutic benefits of MDMA—a.k.a. ecstasy, or molly—in survivors of war combat, sexual assault, violent crimes and other traumatic experiences.

This week, the Food and Drug Administration said researchers could move ahead with the trial after a series of smaller trials proved successful. The bigger Phase 3 trial could pave the way for the agency to approve ecstasy as a legal drug within a few years. Read more…

More about Clinical Trials, Drug Research, Opioid Addiction, Opioids, and Prescription Drugs